Healthcare Unfiltered
by Chadi Nabhan
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇲🇾MY · Medicine#139500 to 3K
- 🇨🇱CL · Medicine#196500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
300 to 1.8K🎙 Daily cadence·274 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 6K🇲🇾50%🇨🇱50% - Active Followers
Loyal subscribers who consistently listen
300 to 1.8K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 21 epsHost
Recent guests
Recent episodes
Episode 294 - How AI Helps Logistics in Oncology: The Story of ZoomLogi
Sep 1, 2026
34m 29s
Episode one: Healthcare Unfiltered - Arabic Edition (بين الفن والطب مع الفنان العالمي أحمد شاكر)
Aug 28, 2026
1h 00m 55s
Episode 293: Managing MPNs and the SENTRY Trial With Prithviraj Bose
Aug 25, 2026
26m 03s
Episode 292 - CELMoDs in Myeloma: A Report From EHA
Aug 18, 2026
27m 31s
CÓMO TOMAMOS DECISIONES EN HEMATOLOGÍA?
Aug 17, 2026
46m 22s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 9/1/26 | Episode 294 - How AI Helps Logistics in Oncology: The Story of ZoomLogi | Chadi Nabhan sits down with Saad Shahzad, co-founder of ZoomLogi, to explore how AI is revolutionizing healthcare logistics by improving the delivery of high-value, time-sensitive therapies, including cell and gene therapies, specialty pharmaceuticals, and biologics. They discuss the costly challenges of shipment delays, chain-of-custody issues, and fragmented supply chain systems, and how ZoomLogi's AI-powered platform provides real-time visibility across carriers, predicts disruptions befor... | 34m 29s | ||||||
| 8/28/26 |  Episode one: Healthcare Unfiltered - Arabic Edition (بين الفن والطب مع الفنان العالمي أحمد شاكر) | On this inagural and special episode of Healthcare Unfiltered -Arabic Edition, Nagla and I host the world-renowned actor and artist, Mr. Ahmed Shaker, who candidly shares his career journey and how he almost went into medicine. Mr. Shaker who speaks 3-4 languages has risen to fame through many series that were watched by millions. He discusses with us how art can help patients and how artists can use their fame, reach, and people's trust to disseminate health information and to help people co... | 1h 00m 55s | ||||||
| 8/25/26 | Episode 293: Managing MPNs and the SENTRY Trial With Prithviraj Bose | World-renowned MPN expert Dr. Prithviraj Bose of MD Anderson Cancer Center joins Chadi to explore the latest advances in myeloproliferative neoplasms (MPNs), including the molecular drivers of polycythemia vera, essential thrombocythemia, and myelofibrosis, and how these discoveries are reshaping patient care. The conversation then turns to the landmark phase 3 SENTRY trial, which evaluated frontline selinexor plus ruxolitinib versus ruxolitinib alone for patients with JAK inhibitor–naïve mye... | 26m 03s | ||||||
| 8/18/26 | Episode 292 - CELMoDs in Myeloma: A Report From EHA | Chadi is joined by two of the world's leading multiple myeloma experts, Dr. Sagar Lonial of Emory University and Dr. Vincent Rajkumar of Mayo Clinic, for an in-depth discussion of the latest advances in multiple myeloma presented at the European Hematology Association (EHA) Congress in Stockholm. They explore the emerging class of cereblon E3 ligase modulators (CELMoDs), explaining how these next-generation therapies differ from existing immunomodulatory drugs, the science behind their mechan... | 27m 31s | ||||||
| 8/17/26 | CÓMO TOMAMOS DECISIONES EN HEMATOLOGÍA? | How is decision-making shaped in hematology? In a setting where evidence from randomized clinical trials, real-world data, and the uncertainties inherent in everyday clinical practice coexist, how do we analyze the available information to make the best treatment decisions for our patients? Cómo se construye la toma de decisiones en hematología? En un escenario donde conviven la evidencia de los estudios clínicos aleatorizados, los datos del mundo real y las incertidumbres inherentes a la prá... | 46m 22s | ||||||
| 8/11/26 | Episode 291: APPs in Oncology With Corinne Shamehdi | Advanced Practice Providers (APPs)—including physician assistants (PAs) and nurse practitioners (NPs)—are playing an increasingly vital role in meeting the growing demand for high-quality cancer care. Corinne Shamehdi, PA-C, a hematology/oncology physician assistant and educator with NCODA, sits down with Chadi and discusses why the APP workforce is expanding, how PAs and NPs are trained, the evolving relationship between APPs and physicians, and addresses common misconceptions surrounding th... | 42m 06s | ||||||
| 8/4/26 | Episode 290: The ChemoCentryx Saga With Anish Koka | Cardiologist and “The Doctor's Lounge” host Anish Koka, MD, joins the show to examine the extraordinary ChemoCentryx and Tavneos (avacopan) controversy, including the retraction of a New England Journal of Medicine clinical trial that played a key role in the drug's FDA approval for ANCA-associated vasculitis. Based on his Substack investigation, Dr. Koka breaks down the timeline of events, the concerns surrounding post hoc changes to trial endpoints, the FDA's response, and the far-reaching ... | 43m 09s | ||||||
| 7/28/26 | Episode 289 - Treating Leukemias: Past and Present With Hagop Kantarjian | In this special episode, Chadi sits down with one of the most influential figures in modern leukemia research and care: Hagop M. Kantarjian, MD, Professor and Samsung Distinguished Leukemia Chair in Cancer Medicine at The University of Texas MD Anderson Cancer Center. Dr. Kantarjian reflects on four decades of progress in leukemia treatment, discussing how the field has evolved from an era of limited therapeutic options to one transformed by groundbreaking scientific advances, while offering ... | 44m 20s | ||||||
| 7/21/26 | leadershipmilitary service+5 | Andy Moye | From Bunker Hill to the Boardroom | — | leadershipempathy+5 | — | 53m 22s | ||
| 7/14/26 | pancreatic cancerRAS inhibition+3 | Tanios S. Bekaii-Saab, MDShubham Pant, MD, MBBS | Mayo ClinicMD Anderson Cancer Center+1 | — | RASolute 302pancreatic cancer+3 | — | 38m 58s | ||
| 7/7/26 | next-generation sequencingcancer+4 | Ezra Cohen | Tempus AIOncology | — | NGScancer continuum+5 | — | 41m 24s | ||
| 7/1/26 | hematologycancer+3 | — | Healthcare UnfilteredFASE 3+1 | — | hematologycancer+3 | — | 43m 52s | ||
| 6/30/26 | cancer journeyresilience+3 | Gabby | — | — | cancerhope+5 | — | 47m 01s | ||
| 6/23/26 | liver transplantationcancer treatment+4 | Maen Abdelrahim | Houston Methodist Neal Cancer Centerliver transplant program | — | liver transplantcancer+4 | — | 39m 06s | ||
| 6/16/26 | Medical Aid in Dyingethics+3 | Dr. Chandana BanerjeeKevin Diaz | City of HopeCompassion & Choices | — | MAIDassisted suicide+5 | — | 50m 42s | ||
| 6/9/26 | TIL therapymelanoma+4 | Dr. Daniel Olson | tumor-infiltrating lymphocyte (TIL) therapyimmunotherapy+2 | — | TIL therapymelanoma+5 | — | 35m 44s | ||
| 5/26/26 | precision oncologycancer care+5 | Dr. Sewanti Limaye | United States | IndiaMumbai | precision oncologyIndia+5 | — | 43m 33s | ||
| 5/19/26 | cancer researchcooperative groups+4 | Sue S. Yom | UCSFInternational Journal of Radiation Oncology Biology Physics+1 | — | cooperative groupscancer research+4 | — | 49m 32s | ||
| 5/12/26 | cell and gene therapycommunity healthcare+3 | Gary L. Simmons, DO, MSHA | cell and gene therapy (CGT)bone marrow transplant+3 | — | cell therapygene therapy+5 | — | 40m 02s | ||
| 5/5/26 | multicancer early detectioncancer diagnostics+4 | Dr. Tom Beer | Exact Sciences | — | multicancer early detectionMCED testing+4 | — | 32m 18s | ||
| 4/28/26 | physician burnoutmental health+4 | Dan Golden, MD, MHPE | Rush University | — | physician burnoutmental toll+5 | — | 50m 07s | ||
| 4/21/26 | radiation therapyGI cancer+5 | Nina Sanford | UT SouthwesternGastrointestinal Radiation Oncology Service | — | radiation therapyGI malignancies+6 | — | 36m 09s | ||
| 4/14/26 | breast cancerhealth management+4 | Amy Comander | Mass General Brigham Cancer InstitutePaving Your Path Through Breast Cancer and Beyond | — | breast canceroncology+5 | — | 44m 05s | ||
| 4/7/26 | food and cancernutritional research+5 | Dr. Urvi Shah | — | — | foodcancer+8 | — | 41m 40s | ||
| 3/31/26 | radiation oncologycancer treatment+4 | Dr. William “Bill” Small, Jr. | Loyola University Chicago | — | radiation oncologycancer+4 | — | 45m 57s | ||
Showing 25 of 296
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Healthcare Unfiltered
Peaked at #139 in MY, currently #139 in MY.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| MY | — | #139 | #139 | — |
| CL | — | #196 | #196 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.